Cargando…
The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance
Epithelial cancer of the ovary exhibits the highest mortality rate of all gynecological malignancies in women today, since the disease is often diagnosed in advanced stages. While the treatment of cancer with specific chemical agents or drugs is the favored treatment regimen, chemotherapy resistance...
Autores principales: | Meng, Yang, Qiu, Lei, Zhang, Su, Han, Junhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019267/ https://www.ncbi.nlm.nih.gov/pubmed/35582023 http://dx.doi.org/10.20517/cdr.2020.115 |
Ejemplares similares
-
Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
por: Hu, Xiaoyan, et al.
Publicado: (2019) -
Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
por: Sun, Aiqin, et al.
Publicado: (2023) -
The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
por: Chen, Xuankun, et al.
Publicado: (2022) -
Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth
por: Hu, Jianguo, et al.
Publicado: (2015) -
Emerging roles of HECT‐type E3 ubiquitin ligases in autophagy regulation
por: Melino, Gerry, et al.
Publicado: (2019)